KLOW Stack
otherGHK-Cu + BPC-157 + TB-500 + KPV (common informal formulation; varies)
Stacks & Combinations
Research status · Not FDA-approved
The combined stack is not FDA-approved and is not a standardized pharmaceutical product. KLOW is an informal vendor/community name; ingredients and ratios vary.
KLOW Stack commonly refers informally to GHK-Cu, BPC-157, TB-500, and KPV. Vendor and community formulations can differ, no fixed ratio is authoritative, and evidence for the combined formulation is limited.
How it works
This is a combination concept, not one studied mechanism. GHK-Cu, BPC-157, TB-500, and KPV each have distinct preclinical or limited component-level evidence; that evidence does not establish safety or effectiveness for the combined stack.
Commonly discussed purpose
- Skin appearance
- Soft-tissue recovery
- Inflammation-related community discussion
Commonly discussed use cases
- Skin and tissue-recovery community discussion
- Inflammation-related community discussion
- Ingredient verification before clinician review
Supposed / potential benefits
- Evidence about individual ingredients does not validate the combined formulation
- No controlled clinical evidence establishes a KLOW stack benefit
Common side effects
- Risks depend on the actual ingredients, route, quality, and user context
- Unverified blends may hide unexpected ingredients
Warnings & contraindications
- Do not assume two vendors mean the same ingredients when they use this name
- Do not treat a stack label as medical evidence or a clinician-approved protocol
- Educational only; this page is not a dosing or combination recommendation
- Unapproved injectable products carry identity, sterility, purity, and legal risks
Typical timing considerations
No established or recommended regimen; the ingredient list itself is not standardized.
Administration route
Varies by vendor formulation
Questions to ask your clinician
- Can we review the exact ingredient list rather than the stack name?
- Are any components approved medicines, investigational compounds, or research chemicals?
- What risks are specific to the proposed route and source?
Commonly tracked in Reta
Tracking fields organize user-entered, clinician-directed routines — Reta never recommends or computes doses.
Track this in Reta
Beta members get a ready-made tracker for KLOW Stack — schedule, dose log, reminders, and check-ins — for organizing a clinician-directed routine. Personal tracking is available to everyone during the Public Beta.
Reta is a tracking and education tool — not a medical provider. Nothing here is a diagnosis, treatment, prescription, or dosing recommendation. Peptides and medications should only be used under the direction of a licensed clinician. Talk to a qualified clinician before starting, stopping, combining, or changing anything. Many compounds below are not FDA-approved for human use; some are investigational or sold through unregulated channels where purity and dosing are not guaranteed.